| Item 8.01. | Other Events. |
On September 3, 2008, ViroPharma Incorporated issued a press release relating to the expiration of the statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, which is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
| Item 9.01 | Financial Statements and Exhibits. |
The following exhibit is attached to this Form 8-K:
| (d) | Exhibit No. | Description | ||
| 99.1 | Press release dated September 3, 2008. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VIROPHARMA INCORPORATED | ||||
| Date: September 3, 2008 | By: | /s/ J. Peter Wolf | ||
| J. Peter Wolf | ||||
| Vice President, General Counsel and Secretary | ||||
Index of Exhibits
| Exhibit |
Description | |
| 99.1 | Press release dated September 3, 2008. |